Bookmark and Share
BioAssay: AID 2473

ELISA Cell-Based Dose Response to Identify Inhibitors of Alpha-Synuclein Translation in SH-SY5Y Cells

Jack T. Rogers, Massachusetts General Hospital, jtrogers@rics.bwh.harvard.edu, 617-726-8838, Charlestown, MA ..more
_
   
 Tested Compounds
 Tested Compounds
All(1)
 
 
Active(1)
 
 
 Tested Substances
 Tested Substances
All(1)
 
 
Active(1)
 
 
 Related BioAssays
 Related BioAssays
AID: 2473
Data Source: Broad Institute (2023-04_INHIBITORS_DOSE-TITRATION_MLPCN-DRYPOWDER>)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network, Assay Provider
BioAssay Version:
Deposit Date: 2010-03-04
Hold-until Date: 2010-09-09
Modify Date: 2010-08-31

Data Table ( Complete ):           Active    All
BioActive Compound: 1
Depositor Specified Assays
AIDNameTypeComment
1813MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitorsscreeningPrimary HTS
1827Broad Institute MLPCN Alpha-Synuclein 5'UTR - InhibitorssummaryProject Summary
Description:
Broad Institute MLPCN Alpha-Synuclein 5'UTR Project

Project ID: 2023

Keywords: alpha-synuclein, Parkinson's disease, translation, RNA stem-loop, 5'-untranslated region

Primary Collaborators (and laboratory where this assay was performed):
Jack T. Rogers, Massachusetts General Hospital, jtrogers@rics.bwh.harvard.edu, 617-726-8838, Charlestown, MA

Project Overview:
The goal of this project is to identify novel small molecule probes that inhibit alpha-synuclein translational expression in dopaminergic neurons by targeting the 5'-untranslated region (5'UTR) stem-loop of alpha-synuclein as a major new therapeutic target to retard the progression of Parkinson's disease (PD). The 5'UTR of alpha-synuclein mRNA can interact with Iron Regulatory Protein-1 (IRP1), which upon interaction causes an increase in alpha-synuclein mRNA translation. Probes that can successfully reduce alpha-synuclein expression levels as measured in this luciferase reporter assay will be further tested for specificity in cells lacking the alpha-synuclein 5'UTR stem-loop to confirm that probes are acting through the intended target. Probe selectivity will be tested in cells containing the prion protein 5'UTR mRNA stem-loop, which is fused to a luciferase reporter.

Assay Overview:
In the ELISA orthogonal screen confirmation of alpha-synuclein tranlation inhibitors was sought. The ELISA used SH-SY5Y neuroglioblastoma cells that were not transfected. Compound was tested in 4-point dose in an effort to observe a dose-response effect.

Expected Outcome:
Inhibitors of alpha-synuclein translation should decrease alpha-synuclein protein levels.
Protocol
ELISA Protocol: (Invitrogen alpha-synuclein ELISA kit #KHB0061)
- Plate 6000 cells/well (50 uL) with phenol red free media
- Incubate 24 hours at 37C, 5% CO2, 95% humidity
- Pin 100 nL of compounds
- Incubate 48 hours at 37C, 5% CO2, 95% humidity
- Add 5uL Alamar blue solution per well, Incubate for 1 Hr at 370C, 5% CO2, 95% humidity
- Read for fluorescence (570nm excitation, 585nm emission)
- Remove media
- Add cell lysis solution and keep the plates on plate shaker for 1 Hr
- Remove 20 uL lysate and place in 500 uL epi tube
- Centrifuge the cell lysate at 13,000 rpm for 10 min
- Transfer 12 uL supernatant to 48 uL of standard diluent buffer (1:5)
- Add 50 uL of Standard curve and other samples on ELISA plate
- Wait 5 min.
- Pipette 50 uL of anti-alpha-Synuclein (Detection Antibody) solution, tap plate to mix
- Cover wells with plate cover and incubate for 3 hours at room temperature
- Wash wells 4 times with wash buffer
- Add 100 uL anti-rabbit IgG-HRP antibody solution
- Cover wells with the plate cover and incubate for 30 mins at RT
- Wash wells 4 times
- Add 100 uL of Stabilized Chromogen
- Keep sealed for 30 minutes at room temperature in the dark
- Add 100 uL of Stop Solution, tap plate to mix
- Read the absorbance of each well at 450 nm
Comment
Dose Response Data Analysis:
Three independent wells were evaluated for each compound concentration. Negative control condition (DMSO) was included.
Live Cell Correction Factor at dose was calculated as:
OD Alamar Blue at dose/ OD Alamar Blue at DMSO

ELISA values are the average of the independent wells for each compound concentration. The ELISA included a standard curve of recombinant alpha-synuclein (provided in the kit). The ELISA value is background normalized to the ELISA kit using the zero condition as described in the kit manual. ELISA values for each compound concentration are adjusted for live cells as follows:
OD ELISA at dose/ Live Cell Correction Factor at dose

The alpha-synuclein concentration values are extrapolated from the recombinant alpha-synuclein standard curve fit equation. Percent inhibition of alpha-synuclein was calculated based on the assumption that complete (100%) inhibition is attainable, as follows:
100 - (100 * (alpha-synuclein concentration at dose/ alpha-synuclein concentration at DMSO))

EC50 was determined to be the lowest dose that supported >= 50% of Maximum Observed Activity.

PUBCHEM_ACTIVITY_SCORE
Inactive compounds = 0
Active compounds = -10 * Log(EC50)

PUBCHEM_ACTIVITY_OUTCOME
Activity_Outcome = 1 (inactive)
Dose Response is not observed.

Activity_Outcome = 2 (active)
Dose Response is observed with an EC50 < 0.2uM.
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1EC50 Qualifier'>', '=', or '<'String
2EC50*the concentration whereupon perceived activity reaches 50% of the maximumFloatμM
3Max. Activitythe maximum activity value observedFloat%
4Activity at 100uM (100μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
5Activity at 6.25uM (6.25μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
6Activity at 0.195uM (0.195μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
7Activity at 0.006uM (0.006μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
8Activity at 0uM (0μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: 1-R21-NS-059434-01

Data Table (Concise)
PageFrom: